Letter

“Polypill” to fight cardiovascular disease: Universal polypharmacy goes against recent beliefs in prescribing practice

BMJ 2003; 327 doi: 10.1136/bmj.327.7418.807-b (Published 2 October 2003)
Cite this as: BMJ 2003;327:807.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Mark Powlson (powlson7@aol.com), managing editor Prescribers' Journal
  1. Bedford MK41 7DY

    EDITOR—Your advocacy of universal polypharmacy—as evidenced by the paper by Wald and Law1—is somewhat against recent beliefs in prescribing practice. Has there been sufficient emphasis on the fact that the proposal is a theoretical construct (admittedly enticing), based on extrapolation of data from many disparate studies, rather than on a trial itself? Indeed, why bother with new trials …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular